{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:44:31Z","timestamp":1793915071401,"version":"4.8.0"},"reference-count":223,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.preghy.2021.09.008","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T09:21:10Z","timestamp":1634030470000},"page":"148-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1169,"special_numbering":"C","title":["The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice"],"prefix":"10.1016","volume":"27","author":[{"given":"Laura A","family":"Magee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Gupte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Hennessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Ananth","family":"Karumanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liona C.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarosh","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Cathrine","family":"Staff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Tsigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"von Dadelszen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2021.09.008_b0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.preghy.2014.01.003","article-title":"Canadian Hypertensive Disorders of Pregnancy Working G. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"4","author":"Magee","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.preghy.2021.09.008_b0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11906-018-0901-z","article-title":"Out of office blood pressure measurement in pregnancy and the postpartum period","volume":"20","author":"Bello","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.preghy.2021.09.008_b0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00126097-200212000-00003","article-title":"Hidden errors of aneroid sphygmomanometers","volume":"7","author":"Waugh","year":"2002","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.preghy.2021.09.008_b0030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/HJH.0000000000000420","article-title":"Comparisons of auscultatory hybrid and automated sphygmomanometers with mercury sphygmomanometry in hypertensive and normotensive pregnant women: parallel validation studies","volume":"33","author":"Davis","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.preghy.2021.09.008_b0035","unstructured":"STRIDEBP. STRIDE-BP: Validated BP monitors in pregnancy. https:\/\/stridebp.org\/bp=monitors Accessed 02 Jan 2021."},{"issue":"606","key":"10.1016\/j.preghy.2021.09.008_b0040","first-page":"e1","article-title":"Challenging the definition of hypertension in pregnancy: a retrospective cohort study","volume":"222","author":"Reddy","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0045","doi-asserted-by":"crossref","first-page":"e1119","DOI":"10.1016\/S2214-109X(21)00219-9","article-title":"Blood pressure thresholds in pregnancy for identifying maternal and infant risk: a secondary analysis of Community-Level Interventions for Pre-eclampsia (CLIP) trial data","volume":"9","author":"Bone","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.preghy.2021.09.008_b0050","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.118.10917","article-title":"How do home and clinic blood pressure readings compare in pregnancy?","volume":"72","author":"Tucker","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0055","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jogc.2018.04.024","article-title":"Choosing wisely: SOGC's top 10 recommendations","volume":"40","author":"Green","year":"2018","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.preghy.2021.09.008_b0060","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.2016.18315","article-title":"Preeclampsia screening: evidence report and systematic review for the US preventive services task force","volume":"317","author":"Henderson","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.preghy.2021.09.008_b0065","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.preghy.2017.11.007","article-title":"Outcome of pregnancy with new onset proteinuria and progression to pre-eclampsia: a retrospective analysis","volume":"12","author":"Chung","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0070","doi-asserted-by":"crossref","first-page":"477","DOI":"10.5694\/j.1326-5377.2002.tb04914.x","article-title":"The clinical utility of routine urinalysis in pregnancy: a prospective study","volume":"177","author":"Murray","year":"2002","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.preghy.2021.09.008_b0075","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/aogs.12915","article-title":"Isolated gestational proteinuria preceding the diagnosis of preeclampsia - an observational study","volume":"95","author":"Yamada","year":"2016","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.preghy.2021.09.008_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004870","article-title":"Clinical features of isolated gestational proteinuria progressing to pre-eclampsia: retrospective observational study","volume":"4","author":"Akaishi","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.preghy.2021.09.008_b0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2471\/BLT.19.248898","article-title":"Population-level data on antenatal screening for proteinuria; India, Mozambique, Nigeria, Pakistan","volume":"98","author":"Magee","year":"2020","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.preghy.2021.09.008_b0090","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.preghy.2015.07.001","article-title":"Should the spot albumin-to-creatinine ratio replace the spot protein-to-creatinine ratio as the primary screening tool for proteinuria in pregnancy?","volume":"5","author":"Cade","year":"2015","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0095","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bmj.39532.543947.BE","article-title":"Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review","volume":"336","author":"Cote","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2021.09.008_b0100","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1471-0528.1997.tb10940.x","article-title":"Improved methods of assessing proteinuria in hypertensive pregnancy","volume":"104","author":"Saudan","year":"1997","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21610","article-title":"Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis","volume":"21","author":"Waugh","year":"2017","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.preghy.2021.09.008_b0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1479-828X.2011.01409.x","article-title":"The accuracy of spot urinary protein-to-creatinine ratio in confirming proteinuria in pre-eclampsia","volume":"52","author":"Cade","year":"2012","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1081\/PRG-120028289","article-title":"A prospective study of the impact of automated dipstick urinalysis on the diagnosis of preeclampsia","volume":"23","author":"Phelan","year":"2004","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.preghy.2021.09.008_b0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12958-021-00751-y","article-title":"Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study","volume":"19","author":"Lei","year":"2021","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.preghy.2021.09.008_b0125","article-title":"Association between proteinuria and maternal and neonatal outcomes in pre-eclampsia pregnancy: a retrospective observational study","volume":"48","author":"Xu","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.preghy.2021.09.008_b0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10641955.2019.1590718","article-title":"The importance of proteinuria in preeclampsia and its predictive role in maternal and neonatal outcomes","volume":"38","author":"Tanacan","year":"2019","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.preghy.2021.09.008_b0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ijgo.12487","article-title":"The impact of proteinuria on maternal and perinatal outcomes among women with pre-eclampsia","volume":"143","author":"Guida","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.preghy.2021.09.008_b0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.preghy.2015.08.001","article-title":"Microalbuminuria is a predictor of adverse pregnancy outcomes including preeclampsia","volume":"5","author":"Jayaballa","year":"2015","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2021.09.008_b0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g2301","article-title":"Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis","volume":"348","author":"Bramham","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2021.09.008_b0155","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1471-0528.2004.00516.x","article-title":"The natural history of white coat hypertension during pregnancy","volume":"112","author":"Brown","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2021.09.008_b0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.preghy.2018.08.452","article-title":"Diagnosis of White Coat Hypertension and pregnancy outcomes","volume":"14","author":"Rodrigues","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0165","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jch.13284","article-title":"Home blood pressure monitoring in the 21st century","volume":"20","author":"Stergiou","year":"2018","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.preghy.2021.09.008_b0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.preghy.2011.09.001","article-title":"Transient gestational hypertension: Not always a benign event","volume":"2","author":"Lee-Ann Hawkins","year":"2012","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0175","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1471-0528.1998.tb09971.x","article-title":"Does gestational hypertension become pre-eclampsia?","volume":"105","author":"Saudan","year":"1998","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0180","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.preghy.2021.09.008_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2021.09.008_b0190","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2021.09.008_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173420","article-title":"Preeclampsia in kidney transplanted women; Outcomes and a simple prognostic risk score system","volume":"12","author":"Majak","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.preghy.2021.09.008_b0200","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/HJH.0b013e3282f1a953","article-title":"Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension","volume":"26","author":"Homer","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0205","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S1701-2163(15)30435-7","article-title":"Uric acid as a predictor of adverse maternal and perinatal outcomes in women hospitalized with preeclampsia","volume":"36","author":"Livingston","year":"2014","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.preghy.2021.09.008_b0210","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1471-0528.2011.03232.x","article-title":"Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study","volume":"119","author":"Hawkins","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2021.09.008_b0215","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015462","article-title":"Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia","volume":"98","author":"Ryu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.preghy.2021.09.008_b0220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","article-title":"Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model","volume":"377","author":"von Dadelszen","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2021.09.008_b0225","article-title":"Biomarkers and the prediction of adverse outcomes in preeclampsia: a systematic review and meta-analysis","author":"Lim","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0230","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.preghy.2021.09.008_b0235","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","article-title":"Short-term prediction of adverse outcomes using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)\/PlGF (placental growth factor) ratio in asian women with suspected preeclampsia","volume":"74","author":"Bian","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0240","article-title":"Placental growth factor in assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a stepped wedge cluster randomised control trial (PARROT Ireland)","volume":"374","author":"Hayes-Ryan","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.preghy.2021.09.008_b0245","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia","volume":"74","author":"Cerdeira","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0250","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/HYPERTENSIONAHA.118.12205","article-title":"Angiogenic factor estimation as a warning sign of preeclampsia-related peripartum morbidity among hospitalized patients","volume":"73","author":"Lopes Perdigao","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0255","unstructured":"NICE. PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1\/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor\/BRAHMS PlGF plus Kryptor PE ratio). Diagnostics guidance [DG23] 2016."},{"key":"10.1016\/j.preghy.2021.09.008_b0260","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2020.11.010","article-title":"Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource SeTting: ROBUST study","volume":"23","author":"Soundararajan","year":"2021","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0265","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study","volume":"77","author":"Droge","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0270","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/uog.17307","article-title":"Comparison of screening for pre-eclampsia at 31\u201334 weeks' gestation by sFlt-1\/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF","volume":"49","author":"Tan","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0275","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/uog.17301","article-title":"Screening for pre-eclampsia using sFlt-1\/PlGF ratio cut-off of 38 at 30\u201337 weeks' gestation","volume":"49","author":"Dragan","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0280","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/uog.22134","article-title":"ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction","volume":"56","author":"Lees","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0285","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.19178","article-title":"Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting","volume":"53","author":"Zeisler","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0290","doi-asserted-by":"crossref","unstructured":"L. Lai, A. Syngelaki, K.H. Nicolaides, P. von Dadelszen, L.A. Magee, Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes. Am. J. Obstet. Gynecol. 2021 May;224(5):518.e1-518.e11. https:\/\/doi.org\/10.1016\/j.ajog.2020.11.004. Epub 2020 Nov 6.","DOI":"10.1016\/j.ajog.2020.11.004"},{"key":"10.1016\/j.preghy.2021.09.008_b0295","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","author":"Rana","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0300","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12916-017-0827-3","article-title":"Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models","volume":"15","author":"Thangaratinam","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.preghy.2021.09.008_b0305","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/aogs.13818","article-title":"Diagnostic accuracy of repeat placental growth factor measurements in women with suspected preeclampsia: a case series study","volume":"99","author":"Duhig","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.preghy.2021.09.008_b0310","article-title":"Real-world data on the clinical use of angiogenic factors in pregnancies with placental dysfunction","author":"Dathan-Stumpf","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0315","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.kint.2015.10.012","article-title":"Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease","volume":"89","author":"Bramham","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.preghy.2021.09.008_b0320","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.111.181735","article-title":"Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy","volume":"59","author":"Perni","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0325","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.preghy.2018.01.004","article-title":"Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia","volume":"15","author":"Ukah","year":"2019","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21180","article-title":"Development and validation of Prediction models for Risks of complications in Early-onset Pre-eclampsia (PREP): a prospective cohort study","volume":"21","author":"Thangaratinam","year":"2017","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.preghy.2021.09.008_b0335","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/HYPERTENSIONAHA.113.02293","article-title":"Angiogenic factors in diagnosis, management, and research in preeclampsia","volume":"63","author":"Rana","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001589","article-title":"A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study","volume":"11","author":"Payne","year":"2014","journal-title":"PLoS Med."},{"key":"10.1016\/j.preghy.2021.09.008_b0345","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1701-2163(15)30358-3","article-title":"Assessing the incremental value of blood oxygen saturation (SpO(2)) in the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model","volume":"37","author":"Payne","year":"2015","journal-title":"J Obstet. Gynaecol. Can."},{"key":"10.1016\/j.preghy.2021.09.008_b0350","doi-asserted-by":"crossref","unstructured":"J. Duffy, A.E. Cairns, D. Richards-Doran, et al. A core outcome set for pre-eclampsia research: an international consensus development study. BJOG 2020;127:1516-26. doi: 10.111\/471-0528.16319.","DOI":"10.1111\/1471-0528.16319"},{"key":"10.1016\/j.preghy.2021.09.008_b0355","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-0528.2000.tb11617.x","article-title":"Expectant management of early onset, severe pre-eclampsia: perinatal outcome","volume":"107","author":"Hall","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2021.09.008_b0360","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/01443610050111940","article-title":"Risk factors for and perinatal mortality of abruptio placentae in patients hospitalised for early onset severe pre-eclampsia \u2013 a case controlled study","volume":"20","author":"Odendaal","year":"2000","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2021.09.008_b0370","doi-asserted-by":"crossref","unstructured":"Z. Alfirevic, T. Stampalija, T. Dowswell, Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane Database Syst Rev 2017;6:CD007529.","DOI":"10.1002\/14651858.CD007529.pub4"},{"key":"10.1016\/j.preghy.2021.09.008_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.11.566","article-title":"Risk of fetal death in growth-restricted fetuses with umbilical and\/or ductus venosus absent or reversed end-diastolic velocities before 34 weeks of gestation: a systematic review and meta-analysis","volume":"218","author":"Caradeux","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0380","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/uog.17361","article-title":"Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study","volume":"50","author":"Visser","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0385","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/uog.18815","article-title":"Severe fetal growth restriction at 26\u201332 weeks: key messages from the TRUFFLE study","volume":"50","author":"Bilardo","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0390","doi-asserted-by":"crossref","first-page":"S783","DOI":"10.1016\/j.ajog.2017.12.226","article-title":"Outcome in early-onset fetal growth restriction is best combining computerized fetal heart rate analysis with ductus venosus Doppler: insights from the Trial of Umbilical and Fetal Flow in Europe","volume":"218","author":"Frusca","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0395","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.preghy.2013.03.001","article-title":"An assessment of predictive value of the biophysical profile in women with preeclampsia using data from the fullPIERS database","volume":"3","author":"Payne","year":"2013","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0400","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/uog.5386","article-title":"Progression of Doppler abnormalities in intrauterine growth restriction","volume":"32","author":"Turan","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0405","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0002-9378(92)91821-Q","article-title":"Numeric analysis of heart rate variation in intrauterine growth-retarded fetuses: a longitudinal study","volume":"166","author":"Snijders","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0410","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.preghy.2015.08.006","article-title":"Development and internal validation of a multivariable model to predict perinatal death in pregnancy hypertension","volume":"5","author":"Payne","year":"2015","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0415","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/uog.19019","article-title":"ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm","volume":"51","author":"Poon","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0420","doi-asserted-by":"crossref","unstructured":"E. Bartsch, K.E. Medcalf, A.L. Park, J.G. Ray, High Risk of Pre-eclampsia Identification G. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ 2016;353:i1753.","DOI":"10.1136\/bmj.i1753"},{"key":"10.1016\/j.preghy.2021.09.008_b0425","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2215\/CJN.09250914","article-title":"A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy","volume":"10","author":"Zhang","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.preghy.2021.09.008_b0430","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.20117","article-title":"Prediction of pre-eclampsia: review of reviews","volume":"54","author":"Townsend","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0435","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/uog.18959","article-title":"Genetic and non-genetic risk factors for pre-eclampsia: umbrella review of systematic reviews and meta-analyses of observational studies","volume":"51","author":"Giannakou","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0440","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/1471-0528.14029","article-title":"The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review","volume":"123","author":"Al-Rubaie","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2021.09.008_b0445","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks' gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O'Gorman","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0450","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0455","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2021.09.008_b0460","unstructured":"https:\/\/fetalmedicine.org\/research\/assess\/preeclampsia\/first-trimester. Accessed 2020 Dec 29."},{"issue":"650","key":"10.1016\/j.preghy.2021.09.008_b0465","first-page":"e1","article-title":"Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population","volume":"221","author":"Chaemsaithong","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0470","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/uog.19077","article-title":"Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0475","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/1471-0528.13194","article-title":"Risk assessment for preeclampsia in nulliparous women at 11\u201313 weeks gestational age: prospective evaluation of two algorithms","volume":"122","author":"Skrastad","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2021.09.008_b0480","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000477934","article-title":"First-trimester combined multimarker prospective study for the detection of pregnancies at a high risk of developing preeclampsia using the fetal medicine foundation-algorithm","volume":"43","author":"Guizani","year":"2018","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.preghy.2021.09.008_b0485","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2017.14498","article-title":"First trimester combined screening for preeclampsia and small for gestational age \u2013 a single centre experience and validation of the FMF screening algorithm","volume":"147","author":"Mosimann","year":"2017","journal-title":"Swiss Med. Wkly."},{"issue":"126","key":"10.1016\/j.preghy.2021.09.008_b0490","first-page":"e1","article-title":"First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume","volume":"218","author":"Sonek","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0495","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ajo.12126","article-title":"Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy","volume":"53","author":"Park","year":"2013","journal-title":"Aust. N Z J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0500","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/14767058.2017.1378332","article-title":"Validation of Fetal Medicine Foundation algorithm for prediction of pre-eclampsia in the first trimester in an unselected Brazilian population","volume":"32","author":"Lobo","year":"2019","journal-title":"J. Matern Fetal Neonatal Med."},{"issue":"68","key":"10.1016\/j.preghy.2021.09.008_b0505","first-page":"1049","article-title":"The cost implications of less tight versus tight control of hypertension in pregnancy (CHIPS Trial)","volume":"2016","author":"Ahmed","year":"1979","journal-title":"Hypertension (Dallas, Tex)"},{"key":"10.1016\/j.preghy.2021.09.008_b0510","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/pd.5554","article-title":"Reasons for accepting or declining participation in the ASPRE trial: a qualitative study with women at high risk of preterm pre-eclampsia","volume":"39","author":"Nikcevic","year":"2019","journal-title":"Prenat Diagn."},{"key":"10.1016\/j.preghy.2021.09.008_b0515","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/bjsports-2018-099355","article-title":"Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: a systematic review and meta-analysis","volume":"52","author":"Davenport","year":"2018","journal-title":"Br. J. Sports Med."},{"key":"10.1016\/j.preghy.2021.09.008_b0520","doi-asserted-by":"crossref","unstructured":"M.F. Mottola, M.H. Davenport, S.M. Ruchat, et al. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy. J. Obstet. Gynaecol. Can. 2018;40:1528-37.","DOI":"10.1016\/j.jogc.2018.07.001"},{"key":"10.1016\/j.preghy.2021.09.008_b0525","doi-asserted-by":"crossref","unstructured":"G.J. Hofmeyr, S. Manyame, N. Medley, M.J. Williams, Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy. Cochrane Database Syst Rev 2019;9:CD011192.","DOI":"10.1002\/14651858.CD011192.pub3"},{"key":"10.1016\/j.preghy.2021.09.008_b0530","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/1471-0528.12613","article-title":"Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary","volume":"121","author":"Hofmeyr","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2021.09.008_b0535","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0140-6736(18)31818-X","article-title":"Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"393","author":"Hofmeyr","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2021.09.008_b0540","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2021.09.008_b0545","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"110\u201320","key":"10.1016\/j.preghy.2021.09.008_b0550","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0555","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.preghy.2021.09.008_b0560","article-title":"Prevention of preeclampsia with aspirin","author":"Rolnik","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0565","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/uog.19076","article-title":"Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia","volume":"53","author":"Ortved","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0570","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pd.2871","article-title":"Economic assessment of screening for pre-eclampsia","volume":"32","author":"Shmueli","year":"2012","journal-title":"Prenat. Diagn."},{"issue":"612","key":"10.1016\/j.preghy.2021.09.008_b0575","first-page":"e1","article-title":"Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit","volume":"218","author":"Wright","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0580","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/AOG.0000000000001115","article-title":"A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States","volume":"126","author":"Werner","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0585","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0000000000003413","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis","volume":"134","author":"Mallampati","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0590","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.118.11718","article-title":"Preeclampsia prevention using routine versus screening test-indicated aspirin in low-risk women","volume":"72","author":"Mone","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0595","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preghy.2021.09.008_b0600","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/AOG.0000000000001301","article-title":"Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses","volume":"127","author":"Ahrens","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0605","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/jch.12541","article-title":"Low-dose aspirin for preventing preeclampsia and its complications: a meta-analysis","volume":"17","author":"Xu","year":"2015","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.preghy.2021.09.008_b0610","first-page":"5013","article-title":"Effect of regular oral intake of aspirin during pregnancy on pregnancy outcome of high-risk pregnancy-induced hypertension syndrome patients","volume":"20","author":"Liu","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.preghy.2021.09.008_b0615","article-title":"Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study","author":"Hastie","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"287\u201393","key":"10.1016\/j.preghy.2021.09.008_b0620","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0625","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1701-2163(16)34346-8","article-title":"Low-dose ASA response using the PFA-100 in women with high-risk pregnancy","volume":"31","author":"Caron","year":"2009","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.preghy.2021.09.008_b0630","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/1471-0528.13914","article-title":"Low dose aspirin and pregnancy: how important is aspirin resistance?","volume":"123","author":"Navaratnam","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2021.09.008_b0635","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejogrb.2017.12.052","article-title":"Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia","volume":"221","author":"Navaratnam","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.preghy.2021.09.008_b0640","article-title":"Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): double blind, phase III, randomised controlled, international, multicentre trial","volume":"362","author":"Wen","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2021.09.008_b0645","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"issue":"68","key":"10.1016\/j.preghy.2021.09.008_b0650","first-page":"1153","article-title":"The CHIPS randomized controlled trial (control of hypertension in pregnancy study): is severe hypertension just an elevated blood pressure?","volume":"2016","author":"Magee","year":"1979","journal-title":"Hypertension (Dallas tex)"},{"key":"10.1016\/j.preghy.2021.09.008_b0655","unstructured":"CMQCC. Improving Health Care Response to Preeclampsia: A California Toolkit to Transform Maternity Care (California Maternal Quality Care Collaborative). https:\/\/www.cmqcc.org\/resources-tool-kits\/toolkits\/preeclampsia-toolkit 2014."},{"key":"10.1016\/j.preghy.2021.09.008_b0660","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1471-0528.1992.tb14384.x","article-title":"Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension?","volume":"99","author":"Crowther","year":"1992","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0665","first-page":"211","article-title":"Is in-patient management of diastolic blood pressure between 90 and 100 mm Hg during pregnancy necessary?","volume":"4","author":"Leung","year":"1998","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.preghy.2021.09.008_b0670","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003514.pub2","article-title":"Bed rest with or without hospitalisation for hypertension during pregnancy","author":"Meher","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preghy.2021.09.008_b0675","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/HYPERTENSIONAHA.117.10689","article-title":"Influence of gestational age at initiation of antihypertensive therapy: secondary analysis of CHIPS trial data (control of hypertension in pregnancy study)","volume":"71","author":"Pels","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0680","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/HYPERTENSIONAHA.116.07190","article-title":"Post-control of hypertension in pregnancy study (CHIPS): what is the optimal strategy to manage hypertension during pregnancy?","volume":"68","author":"Easterling","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0685","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/AOG.0000000000002479","article-title":"Use of antihypertensive medications during delivery hospitalizations complicated by preeclampsia","volume":"131","author":"Cleary","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0690","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"10","author":"Abalos","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preghy.2021.09.008_b0695","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/AOG.0000000000002751","article-title":"Maternal outcomes by race for women aged 40 years or older","volume":"132","author":"Booker","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"337","key":"10.1016\/j.preghy.2021.09.008_b0700","first-page":"e1","article-title":"Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study","volume":"212","author":"Bateman","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0705","unstructured":"Identification and Management of Neonatal Hypoglycaemia in the Full Term Infant (2017). A BAPM Framework for Practice. https:\/\/www.bapm.org\/resources\/40-identification-and-management-of-neonatal-hypoglycaemia-in-the-full-term-infant-2017 2017."},{"key":"10.1016\/j.preghy.2021.09.008_b0710","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/HJH.0000000000001456","article-title":"In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review","volume":"35","author":"Fitton","year":"2017","journal-title":"J. Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0715","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/1471-0528.16186","article-title":"Effects of tocolysis with nifedipine or atosiban on child outcome: follow-up of the APOSTEL III trial","volume":"127","author":"van Winden","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2021.09.008_b0720","first-page":"526","article-title":"Hypertension Canada's 2018 guidelines for the management of hypertension in pregnancy","volume":"34","author":"Butalia","year":"2018","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.preghy.2021.09.008_b0725","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/jhh.2016.50","article-title":"A prediction model for the response to oral labetalol for the treatment of antenatal hypertension","volume":"31","author":"Stott","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0730","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/uog.17341","article-title":"Serial hemodynamic monitoring to guide treatment of maternal hypertension leads to reduction in severe hypertension","volume":"49","author":"Stott","year":"2017","journal-title":"Ultrasound Obstetrics Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0735","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/HJH.0000000000002233","article-title":"Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study","volume":"38","author":"Weber-Schoendorfer","year":"2020","journal-title":"J. Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0740","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preghy.2018.09.010","article-title":"Maternal and perinatal outcomes associated with the use of renin-angiotensin system (RAS) blockers for chronic hypertension in early pregnancy","volume":"14","author":"Ahmed","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0745","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/01443615.2011.579197","article-title":"Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers","volume":"31","author":"Walfisch","year":"2011","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0750","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/AOG.0000000000001775","article-title":"Angiotensin-converting enzyme inhibitors and the risk of congenital malformations","volume":"129","author":"Bateman","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0755","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/HYPERTENSIONAHA.116.08773","article-title":"Maternal antihypertensive medication use and congenital heart defects: updated results from the national birth defects prevention study","volume":"69","author":"Fisher","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0760","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","article-title":"Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review","volume":"60","author":"Bullo","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b0765","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.preghy.2018.07.010","article-title":"Timely treatment of severe maternal hypertension and reduction in severe maternal morbidity","volume":"14","author":"Gupta","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0770","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","article-title":"Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis","volume":"327","author":"Magee","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2021.09.008_b0775","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1479-828X.2007.00738.x","article-title":"A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial","volume":"47","author":"Hennessy","year":"2007","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0780","article-title":"Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension","author":"Scott","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0785","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/bcp.13649","article-title":"Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials","volume":"84","author":"Sridharan","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.preghy.2021.09.008_b0790","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.preghy.2019.09.019","article-title":"First-line antihypertensive treatment for severe hypertension in pregnancy: A systematic review and network meta-analysis","volume":"18","author":"Alavifard","year":"2019","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b0795","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(19)31282-6","article-title":"Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial","volume":"394","author":"Easterling","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2021.09.008_b0800","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001449.pub3","article-title":"Drugs for treatment of very high blood pressure during pregnancy","author":"Duley","year":"2013","journal-title":"Cochrane Database System. Rev."},{"key":"10.1016\/j.preghy.2021.09.008_b0805","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1080\/14767058.2018.1514381","article-title":"Implementation of a standardized nurse initiated protocol to manage severe hypertension in pregnancy","volume":"33","author":"Miller","year":"2020","journal-title":"J. Matern Fetal Neonatal Med."},{"issue":"250","key":"10.1016\/j.preghy.2021.09.008_b0810","first-page":"e1","article-title":"Identification of factors associated with delayed treatment of obstetric hypertensive emergencies","volume":"223","author":"Kantorowska","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0815","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ajog.2004.11.059","article-title":"Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia","volume":"193","author":"Magee","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0820","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijoa.2017.12.004","article-title":"The influence of fluid management on outcomes in preeclampsia: a systematic review and meta-analysis","volume":"34","author":"Pretorius","year":"2018","journal-title":"Int. J. Obstet. Anesth."},{"key":"10.1016\/j.preghy.2021.09.008_b0825","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-0528.2005.00687.x","article-title":"A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia","volume":"112","author":"Ganzevoort","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2021.09.008_b0830","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/10641950902972140","article-title":"Acute pulmonary oedema as a complication of hypertension during pregnancy","volume":"30","author":"Thornton","year":"2011","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.preghy.2021.09.008_b0835","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(05)79550-7","article-title":"Magnesium sulphate in eclampsia. Eclampsia Trial Collaborative Group","volume":"352","author":"Duley","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2021.09.008_b0840","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"Altman","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2021.09.008_b0845","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1471-0528.2005.00785.x","article-title":"Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial","volume":"113","author":"Simon","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2021.09.008_b0850","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/aogs.12807","article-title":"Alternative regimens of magnesium sulfate for treatment of preeclampsia and eclampsia: a systematic review of non-randomized studies","volume":"95","author":"Pratt","year":"2016","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.preghy.2021.09.008_b0855","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jogc.2018.09.018","article-title":"No. 376-magnesium sulphate for fetal neuroprotection","volume":"41","author":"Magee","year":"2019","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.preghy.2021.09.008_b0860","unstructured":"M. Knight, K. Bunch, D. Tuffnell, et al. (Eds.) on behalf of MBRRACE-UK. Saving Lives, Improving Mothers\u2019 Care \u2013 Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2015-17. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2019."},{"issue":"514","key":"10.1016\/j.preghy.2021.09.008_b0865","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2007.04.021","article-title":"Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications","volume":"196","author":"Sibai","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0870","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bpobgyn.2011.01.004","article-title":"Temporising versus interventionist management (preterm and at term)","volume":"25","author":"Ganzevoort","year":"2011","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0875","doi-asserted-by":"crossref","unstructured":"D. Churchill, L. Duley, J.G. Thornton, M. Moussa, H.S. Ali, K.F. Walker. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation. Cochrane Database Syst Rev 2018;10:CD003106.","DOI":"10.1002\/14651858.CD003106.pub3"},{"key":"10.1016\/j.preghy.2021.09.008_b0880","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0140-6736(19)31963-4","article-title":"Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial","volume":"394","author":"Chappell","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2021.09.008_b0885","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(14)61998-X","article-title":"Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial","volume":"385","author":"Broekhuijsen","year":"2015","journal-title":"Lancet (london, england)"},{"key":"10.1016\/j.preghy.2021.09.008_b0890","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/uog.20224","article-title":"Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis","volume":"53","author":"Bernardes","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.preghy.2021.09.008_b0895","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejogrb.2019.11.001","article-title":"Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 5-year outcomes of the HYPITAT II trial","volume":"244","author":"Zwertbroek","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.preghy.2021.09.008_b0900","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijgo.2014.04.010","article-title":"Pregnancy outcomes of expectant management of stable mild to moderate chronic hypertension as compared with planned delivery","volume":"127","author":"Hamed","year":"2014","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.preghy.2021.09.008_b0905","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(09)60736-4","article-title":"Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial","volume":"374","author":"Koopmans","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2021.09.008_b0910","unstructured":"Hypertension in pregnancy: diagnosis and management. 2019. at https:\/\/www.nice.org.uk\/guidance\/ng133.)."},{"issue":"214","key":"10.1016\/j.preghy.2021.09.008_b0915","first-page":"e1","article-title":"What is the optimal time for delivery in women with gestational hypertension?","volume":"207","author":"Cruz","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0920","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/AOG.0000000000002800","article-title":"Timing of delivery in women with chronic hypertension","volume":"132","author":"Ram","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0925","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1471-0528.2010.02754.x","article-title":"Optimal timing of delivery in pregnancies with pre-existing hypertension","volume":"118","author":"Hutcheon","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2021.09.008_b0930","doi-asserted-by":"crossref","unstructured":"E. McGoldrick, F. Stewart, R. Parker, S.R. Dalziel, Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst. Rev., 2020;12:CD004454.","DOI":"10.1002\/14651858.CD004454.pub4"},{"key":"10.1016\/j.preghy.2021.09.008_b0935","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.semperi.2019.03.012","article-title":"Antenatal corticosteroids for low and middle income countries","volume":"43","author":"Jobe","year":"2019","journal-title":"Semin Perinatol."},{"key":"10.1016\/j.preghy.2021.09.008_b0940","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/AOG.0000000000001715","article-title":"Committee Opinion No.677: Antenatal Corticosteroid Therapy for Fetal Maturation","volume":"128","author":"American College of O, Gynecologists'","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0945","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal Betamethasone for Women at Risk for Late Preterm Delivery","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.preghy.2021.09.008_b0950","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008148.pub2","article-title":"Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy","author":"Woudstra","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preghy.2021.09.008_b0955","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/01443615.2018.1525609","article-title":"Effects of high-dose dexamethasone in postpartum women with class 1 haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome","volume":"39","author":"Takahashi","year":"2019","journal-title":"J. Obstet. Gynaecol"},{"key":"10.1016\/j.preghy.2021.09.008_b0960","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.placenta.2020.08.022","article-title":"Novel approaches to combat preeclampsia: from new drugs to innovative delivery","volume":"102","author":"de Alwis","year":"2020","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2021.09.008_b0965","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"203: Chronic Hypertension in Pregnancy","volume":"133","author":"ACOG Practice Bulletin No","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b0970","unstructured":"S.H. Nasab, H.N. Moussa, M.A. Alrais, BM. Sibai, Postpartum readmissions: what we can learn from numbers? [18K]. Obstetr. Gynecol. 2018;131:1235. 10.097\/01.AOG.0000533520.08596.85."},{"key":"10.1016\/j.preghy.2021.09.008_b0975","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/bmj.309.6966.1395","article-title":"Eclampsia in the United Kingdom","volume":"309","author":"Douglas","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2021.09.008_b0980","unstructured":"Drugs and Lactation Database (LactMed) [Internet]. National Library of Medicine (US), 2006-. at https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501922\/?term=lactmed.)."},{"key":"10.1016\/j.preghy.2021.09.008_b0985","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018696","article-title":"Postpartum management of hypertensive disorders of pregnancy: a systematic review","volume":"7","author":"Cairns","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.preghy.2021.09.008_b0990","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009382","article-title":"Hypertensive disorders of pregnancy and future maternal cardiovascular risk","volume":"7","author":"Ying","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"72","key":"10.1016\/j.preghy.2021.09.008_b0995","first-page":"425","article-title":"Self-management of postnatal hypertension: the SNAP-HT Trial","volume":"2018","author":"Cairns","year":"1979","journal-title":"Hypertension (Dallas, tex)"},{"key":"10.1016\/j.preghy.2021.09.008_b1000","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1089\/bfm.2018.0108","article-title":"Effect of lactation on maternal hypertension: a systematic review","volume":"13","author":"Bonifacino","year":"2018","journal-title":"Breastfeed Med."},{"key":"10.1016\/j.preghy.2021.09.008_b1005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ypmed.2018.06.014","article-title":"Breastfeeding and later maternal risk of hypertension and cardiovascular disease \u2013 the role of overall and abdominal obesity","volume":"114","author":"Kirkegaard","year":"2018","journal-title":"Prev. Med."},{"key":"10.1016\/j.preghy.2021.09.008_b1010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ajog.2003.08.030","article-title":"Postpartum hypertension and nonsteroidal analgesia","volume":"190","author":"Makris","year":"2004","journal-title":"Am J Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b1015","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/AOG.0000000000002247","article-title":"Association of nonsteroidal antiinflammatory drugs and postpartum hypertension in women with preeclampsia with severe features","volume":"130","author":"Viteri","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b1020","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/AOG.0000000000002979","article-title":"Nonsteroidal antiinflammatory drug administration and postpartum blood pressure in women with hypertensive disorders of pregnancy","volume":"132","author":"Anastasio","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b1025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.preghy.2014.06.001","article-title":"Impact of non-steroidal anti-inflammatory drugs on hypertensive disorders of pregnancy","volume":"4","author":"Wasden","year":"2014","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.09.008_b1030","doi-asserted-by":"crossref","unstructured":"N.R. Blue, C. Murray-Krezan, S. Drake-Lavelle, et al. Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial. Am. J. Obstetr. Gynecol. 2018;218:616.e1-.e8.","DOI":"10.1016\/j.ajog.2018.02.016"},{"key":"10.1016\/j.preghy.2021.09.008_b1035","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/14767058.2016.1210599","article-title":"Ibuprofen versus acetaminophen as a post-partum analgesic for women with severe pre-eclampsia: randomized clinical study","volume":"30","author":"Vigil-De Gracia","year":"2017","journal-title":"J. Matern. Fetal Neona"},{"issue":"624","key":"10.1016\/j.preghy.2021.09.008_b1040","first-page":"e1","article-title":"Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis","volume":"212","author":"van Oostwaard","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.008_b1045","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1471-0528.2007.01376.x","article-title":"Can we predict recurrence of pre-eclampsia or gestational hypertension?","volume":"114","author":"Brown","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2021.09.008_b1050","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/HYPERTENSIONAHA.121.16506","article-title":"Long-term cardiovascular disease risk in women after hypertensive disorders of pregnancy: recent advances in hypertension","volume":"78","author":"Khosla","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.09.008_b1055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/AOG.0000000000001534","article-title":"All-cause and cause-specific mortality after hypertensive disease of pregnancy","volume":"128","author":"Theilen","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"70","key":"10.1016\/j.preghy.2021.09.008_b1060","first-page":"798","article-title":"All hypertensive disorders of pregnancy increase the risk of future cardiovascular disease","volume":"2017","author":"Tooher","year":"1979","journal-title":"Hypertension (Dallas, tex)"},{"key":"10.1016\/j.preghy.2021.09.008_b1065","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1089\/jwh.2018.7523","article-title":"Randomized trial to reduce cardiovascular risk in women with recent preeclampsia","volume":"28","author":"Rich-Edwards","year":"2019","journal-title":"J. Womens Health (Larchmt)"},{"key":"10.1016\/j.preghy.2021.09.008_b1070","unstructured":"My Health Beyond Pregnancy. 2021. at https:\/\/preeclampsia.org\/beyondpregnancy.)."},{"key":"10.1016\/j.preghy.2021.09.008_b1075","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018604","article-title":"Recognizing cardiovascular risk after preeclampsia: the P4 study","volume":"9","author":"Brown","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.preghy.2021.09.008_b1080","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/2047487319879791","article-title":"Risk prediction of maternal cardiovascular disease one year after hypertensive pregnancy complications or gestational diabetes mellitus","volume":"27","author":"Moe","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.preghy.2021.09.008_b1085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/M17-2740","article-title":"Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development: an observational cohort study","volume":"169","author":"Stuart","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.preghy.2021.09.008_b1090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.preghy.2018.02.003","article-title":"Maternal pre-eclampsia and long-term offspring health: is there a shadow cast?","volume":"12","author":"Goffin","year":"2018","journal-title":"Pregnancy Hypertens."},{"issue":"69","key":"10.1016\/j.preghy.2021.09.008_b1095","first-page":"591","article-title":"Hypertension in pregnancy and offspring cardiovascular risk in young adulthood: prospective and sibling studies in the HUNT study (nord-trondelag health study) in Norway","volume":"2017","author":"Alsnes","year":"1979","journal-title":"Hypertension (Dallas, Tex)"},{"key":"10.1016\/j.preghy.2021.09.008_b1100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bmjinnov-2017-000235","article-title":"Development and evaluation of a novel Vital Signs Alert device for use in pregnancy in low-resource settings","volume":"4","author":"Nathan","year":"2018","journal-title":"BMJ Innov."},{"key":"10.1016\/j.preghy.2021.09.008_b1105","series-title":"World Health Organization Model List of Essential Medicines","author":"WHO","year":"2019"},{"key":"10.1016\/j.preghy.2021.09.008_b1110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(20)31128-4","article-title":"The community-level interventions for pre-eclampsia (CLIP) cluster randomised trials in Mozambique, Pakistan, and India: an individual participant-level meta-analysis","volume":"396","author":"von Dadelszen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2021.09.008_b1115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113715","article-title":"Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines","volume":"9","author":"Gillon","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921005237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921005237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:56:30Z","timestamp":1761897390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778921005237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":223,"alternative-id":["S2210778921005237"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2021.09.008","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2021.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}